{"id":"W2112228502","doi":"10.1517/13543784.12.1.87","title":"Therapeutic potential of dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetes","year":2003,"lang":"en","type":"article","venue":"Expert Opinion on Investigational Drugs","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Incretin; Dipeptidyl peptidase; Aminopeptidase; Peptide; Glucagon-like peptide-1; Dipeptidyl peptidase-4; Type 2 diabetes; Sitagliptin; Chemistry; Pharmacology; Biochemistry; Endocrinology; Internal medicine; Biology; Diabetes mellitus; Medicine; Enzyme; Amino acid","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006219809,0.0004537976,0.0008047486,0.0004444526,0.0002164285,0.0007435973,0.0003890696,0.0008813366,0.003606349],"category_scores_gemma":[0.0002893412,0.0001163268,0.0003727471,0.0002105353,0.00028492,0.0004830829,0.0002464976,0.001181256,0.0009054065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003199494,"about_ca_system_score_gemma":0.0003385249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001809938,"about_ca_topic_score_gemma":0.0005706956,"domain_scores_codex":[0.9998538,0.00005838706,0.0000112059,0.00001532781,0.00004010661,0.00002111981],"domain_scores_gemma":[0.9999173,0.00003780796,0.00001431768,0.000003336208,0.00001400224,0.00001333499],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001279298,0.0004815974,0.0005902885,0.001969854,0.0001147521,0.001891839,0.00009993823,0.0008617762,0.05165763,0.01294403,0.01220208,0.9159068],"study_design_scores_gemma":[0.002747022,0.006316775,0.004751651,0.001505357,0.0005182042,0.01006556,0.0003195797,0.002232854,0.03203225,0.01780071,0.9216303,0.00007970356],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.02295434,0.9315499,0.005846643,0.01186133,0.001361071,0.0001110776,0.00008908504,0.00008825432,0.02613825],"genre_scores_gemma":[0.2059712,0.761682,0.01372381,0.004914982,0.001895165,0.0002103707,0.00016614,0.00002057301,0.01141571],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003606349,"threshold_uncertainty_score":0.01206446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02959327137273806,"score_gpt":0.2913622153120864,"score_spread":0.2617689439393484,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}